Arm and leg workout combo may ease daily struggles for COPD patients

NCT ID NCT05708443

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether combining arm and leg endurance training is better than leg training alone for improving daily activities in people with COPD. 36 participants with moderate-to-severe COPD will undergo 14 supervised sessions. The main goal is to see if the combined training reduces the time needed to complete a daily task test (GLITTRE test).

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
exercise training (combined upper and lower extremity endurance training vs lower extremity training alone)
What this could lead to
If it works, this could show that adding arm exercises to standard leg training helps people with COPD do daily activities more easily.
What could go wrong
This is a small, early-stage trial with only 36 participants, so results may not apply to all COPD patients. The benefit of adding arm training may be small or not significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ICS Maugeri IRCCS, Respiratory rehabilitation of the Institute of Lumezzane

    RECRUITING

    Lumezzane, Brescia, 25065, Italy

  • ICS Maugeri IRCCS, Respiratory rehabilitation of the Institute of Montescano

    NOT_YET_RECRUITING

    Montescano, Pavia, 27040, Italy

  • ICS Maugeri IRCCS, Respiratory rehabilitation of the Institute of Tradate

    COMPLETED

    Tradate, Varese, 21049, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.